No profile data available.
Xwell, Inc. (XWEL) is an essential consumer products company in the additional individual service operations industry, based in New York, United States, with about 175 full-time employees.
It reported revenue of $29.21 million for fiscal year 2025, down 13.8% from fiscal year 2024, and net income of -$28.23 million. Its largest business segment, Xpresspa, brought in 64% of segment revenue in fiscal year 2025; United States was the largest region with 80%. Its market capitalization was $7.89 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. S.
Xwell reported $29.21 million in revenue for fiscal year 2025, down 13.8% from $33.90 million in fiscal year 2024.
Xpresspa, with $18.65 million or 64% of segment revenue in fiscal year 2025. Next: Xprestest (28%) and Naples Wax (8%).
United States: 80% of revenue by region in fiscal year 2025, followed by ALL Other Countries (20%).
$7.89 million as of October 8, 2026.
Listed companies of a similar size in the same industry (additional individual service operations) include Shonghoya Intl Group Inc. (SNHO), Vanguard Green Investment Limited (VGES), Medirom Healthcare Technologies Inc. (MRM), Quest Patent Research Corporation (QPRC).